Persistence of an intact endometrial matrix and vessels structure in women exposed to VA-2914, a selective progesterone receptor modulator

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 11, 2008, Pages 4525-4531

  Ravet, S ^a   Munaut, C ^b   Blacher, S ^b   Brichant, G ^a   Labied, S ^b   Beliard, A ^a,b   Chabbert Buffet, N ^c,d   Bouchard, P ^c,d   Foidart, Jean Michel ^a,b,e   Pintiaux, A ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e Service de Gynecologie Obstetrique   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; VA 2914; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM BIOPSY; FEMALE; HISTOLOGY; HUMAN; HUMAN EXPERIMENT; IMMUNOHISTOCHEMISTRY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION;

EID: 57349106097     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0731     Document Type: Article

References (24)

1. Galant C, Vekemans M, Lemoine P, Kokorine I, Twagirayezu P, Henriet P, Picquet C, Rigot V, Eeckhout Y, Courtoy PJ, Marbaix E 2000 Temporal and spatial association of matrix metalloproteinases with focal endometrial breakdown and bleeding upon progestin-only contraception. J Clin Endocrinol Metab 85:4827-4834
2. Stéphanie R, Labied S, Blacher S, Frankenne F, Munaut C, Fridman V, Beliard A, Foidart JM, Nisolle M 2007 Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time. Hum Reprod 22:3084-3091
3. Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM 2005 Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum Reprod Update 11:293-307
4. Wagner BL, Pollio G, Giangrande P, Webster JC, Breslin M, Mais DE, Cook CE, Vedeckis WV, Cidlowski JA, McDonnell DP 1999 The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestins. Endocrinology 140:1449-1458
5. Larner JM, Reel JR, Blye RP 2000 Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration. Hum Reprod 15:1100-1106
6. Hild SA, Reel JR, Hoffman LH, Blye RP 2000 CDB-2914: anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits. Hum Reprod 15:822-829
7. Reel JR, Hild-Petito S, Blye RP 1998 Antiovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats. Contraception 58:129-136
8. Creinin MD, Schlaff W, Archer DF, Wan L, Frezieres R, Thomas M, Rosenberg M, Higgins J 2006 Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 108:1089-1097
9. Stratton P, Hartog B, Hajizadeh N, Piquion J, Sutherland D, Merino M, Lee YJ, Nieman LK 2000 A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women. Hum Reprod 15:1092-1099
10. Chabbert-Buffet N, Pintiaux-Kairis A, Bouchard P, VA2914 Study Group 2007 Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo controlled trial. J Clin Endocrinol Metab 92:3582-3589
11. Smith SK 2001 Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab 12:147-151
12. Noyes RW, Hertig AT, Rock J 1950 Dating the endometrial biopsy. Fertil Steril 1:3-25
13. Narvekar N, Critchley HO, Cheng L, Baird DT 2006 Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor. Hum Reprod 21:2312-2318
14. Narvekar N, Cameron S, Critchley HO, Lin S, Cheng L, Baird DT 2004 Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor. J Clin Endocrinol Metab 89:2491-2497
15. Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, Slayden OD, Millar MR, Saunders PT 2001 Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 86:1370-1378
16. Wang H, Critchley HO, Kelly RW, Shen D, Baird DT 1998 Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol Hum Reprod 4:407-412
17. Gordon H, Sweets Jr HH 1936 A simple method for the silver impregnation of reticulum. Am J Pathol 12:545-551
18. Russ JC 1999 Processing binary images. In: The image processing handbook. 3rd ed. Boca Raton, FL: CRC press; 431-508
19. Galant C, Berliere M, Dubois D, Verougstraete JC, Charles A, Lemoine P, Kokorine I, Eeckhout Y, Courtoy PJ, Marbaix E 2004 Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding. Am J Pathol 165:83-94
20. Horne FM, Blithe DL 2007 Progesterone receptor modulators and the endometrium: changes and consequences. Hum Reprod Update 13:567-580
21. Mutter G, Bergeron C, Deligdisch L, Ferenczy A, Glant M, Merino M, Williams AR, Blithe DL 2008 The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol 21:591-598
22. Williams AR, Critchley HO, Osei J, Ingamells S, Cameron IT, Han C, Chwalisz K 2007 The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata. Hum Reprod 22:1696-1704
23. Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H 2002 Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 123:379-387
24. Gargett CE, Lederman FL, Lau TM, Taylor NH, Rogers PA 1999 Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium. Hum Reprod 14:2080-2088